Trials / Completed
CompletedNCT04097847
Osteoradionecrosis and PENTOCLO Protocol: Retrospective Study
Osteoradionecrosis and PENTOCLO Protocol: Retrospective Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 96 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
osteoradionecrosis (ORN) affects up to 30% of irradiated patients and can occur up to several decades after stopping treatment. Differents therapeutics exist but there is no consensus concerning the management of the maxillary ORN. The understanding of new pathological mechanisms opens the way to new therapeutic perspectives.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pentoxifylline-Tocopherol-Clodronate | the aim of this retrospective study is to analyze from patient records the impact of the PENTOCLO protocol on maxillofacial osteoradionecrosis at Brest Hospital University, France. |
Timeline
- Start date
- 2017-06-02
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2019-09-20
- Last updated
- 2019-11-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04097847. Inclusion in this directory is not an endorsement.